Vitamin D3-induced changes in steroidogenic pathway within periovarian adipose tissue of rats with polycystic ovary syndrome*
References
- Abban G., Yildirim N.B., Jetten A.M. (2008). Regulation of the vitamin D receptor and cornifin beta expression in vaginal epithelium of the rats through vitamin D3. Eur. J. Histochem., 52: 107–114.
- Ashraf S., Nabi M., Rasool Su A., Rashid F., Amin S. (2019). Hyperandrogenism in polycystic ovarian syndrome and role of CYP gene variants: a review. Egypt. J. Med. Hum. Genet., 20: 25.
- Azziz R., Carmina E., Chen Z., Dunaif A., Laven J.S., Legro R.S., Lizneva D., Natterson-Horowtiz B., Teede H.J., Yildiz B.O. (2016). Polycystic ovary syndrome. Nat. Rev. Dis. Primers, 2: 16057.
- Baba T. (2025). Polycystic ovary syndrome: Criteria, phenotypes, race and ethnicity. Reprod. Med. Biol., 24: e12630.
- Bakhshalizadeh S., Amidi F., Alleyassin A., Soleimani M., Shirazi R., Shabani Nashtaei M. (2017). Modulation of steroidogenesis by vitamin D3 in granulosa cells of the mouse model of polycystic ovarian syndrome. Syst. Biol. Reprod. Med., 63: 150–161.
- Bakhshalizadeh S., Amidi F., Shirazi R., Shabani Nashtaei M. (2018). Vitamin D3 regulates steroidogenesis in granulosa cells through AMP-activated protein kinase (AMPK) activation in a mouse model of polycystic ovary syndrome. Cell. Biochem. Funct., 36: 183–193.
- Baravalle C., Salvetti N.R., Mira G.A., Pezzone N., Ortega H.H. (2006). Microscopic characterization of follicular structures in letrozole-induced polycystic ovarian syndrome in the rat. Arch. Med. Res., 37: 830–839.
- Behmanesh N., Abedelahi A., Charoudeh H.N., Alihemmati A. (2019). Effects of vitamin D supplementation on follicular development, gonadotropins and sex hormone concentrations, and insulin resistance in induced polycystic ovary syndrome. Turk. J. Obstet. Gynecol., 16: 143–150.
- Benrick A., Chanclón B., Micallef P., Wu Y., Hadi L., Shelton J.M., Stener-Victorin E., Wernstedt Asterholm I. (2017). Adiponectin protects against development of metabolic disturbances in a PCOS mouse model. Proc. Natl. Acad. Sci. USA, 114: E7187–E7196.
- Borges C.C., Bringhenti I., Aguila M.B., Mandarim-de-Lacerda C.A. (2020). Vitamin D restriction enhances periovarian adipose tissue inflammation in a model of menopause. Climacteric, 23: 99–104.
- Bril F., Ezeh U., Amiri M., Hatoum S., Pace L., Chen Y.H., Bertrand F., Gower B., Azziz R. (2023). Adipose tissue dysfunction in polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 109: 10–24.
- Byeon H.R., Lee S.H. (2016). Expression of steroidogenesis-related genes in rat adipose tissues. Dev. Reprod., 20: 197–205.
- Caldwell A.S., Middleton L.J., Jimenez M., Desai R., McMahon A.C., Allan C.M., Handelsman D.J., Walters K.A. (2014). Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models. Endocrinology, 155: 3146.
- Caron-Jobin M., Morisset A.S., Tremblay A., Huot C., Légaré D., Tchernof A. (2011). Elevated serum 25(OH)D concentrations, vitamin D, and calcium intakes are associated with reduced adipocyte size in women. Obesity, 19: 1335–1341.
- Chang E. (2022). Effects of vitamin D supplementation on adipose tissue inflammation and NF-κB/AMPK activation in obese mice fed a high-fat diet. Int. J. Mol. Sci., 23: 10915.
- Dicken C.L., Israel D.D., Davis J.B., Sun Y., Shu J., Hardin J., Neal-Perry G. (2012). Peripubertal vitamin D3 deficiency delays puberty and disrupts the estrous cycle in adult female mice. Biol. Reprod., 87: 51.
- Dipali S.S., Ferreira C.R., Zhou L.T., Pritchard M.T., Duncan F.E. (2019). Histologic analysis and lipid profiling reveal reproductive age-associated changes in peri-ovarian adipose tissue. Reprod. Biol. Endocrinol., 17: 46.
- Emami N., Moini A., Yaghmaei P., Akbarinejad V., Shahhoseini M., Alizadeh A. (2021). Differences in expression of genes related to steroidogenesis in abdominal subcutaneous adipose tissue of pregnant women with and without PCOS; a case control study. BMC Pregnancy Childbirth, 21: 490.
- Enjuanes A., Garcia-Giralt N., Supervia A., Nogués X., Mellibovsky L., Carbonell J., Grinberg D., Balcells S., Díez-Pérez A. (2003). Regulation of CYP19 gene expression in primary human osteoblasts: effects of vitamin D and other treatments. Eur. J. Endocrinol., 148: 519–526.
- Grzesiak M., Burzawa G., Kurowska P., Blaszczyk K., Szlaga A., Blasiak A., Sechman A., Rak A. (2021). Altered vitamin D3 metabolism in the ovary and periovarian adipose tissue of rats with letrozole-induced PCOS. Histochem. Cell Biol., 155: 101–116.
- Grzesiak M., Kaminska K., Knapczyk-Stwora K., Hrabia A. (2022). The expression and localization of selected matrix metalloproteinases (MMP-2, -7 and -9) and their tissue inhibitors (TIMP-2 and -3) in follicular cysts of sows. Theriogenology, 185: 109–120.
- Grzesiak M., Herian M., Kamińska K., Ajersch P. (2024). Insight into vitamin D3 action within the ovary – Basic and clinical aspects. Adv. Protein Chem. Struct. Biol., 142: 99–130.
- Helvaci N., Yildiz B.O. (2025). Polycystic ovary syndrome as a metabolic disease. Nat. Rev. Endocrinol., 21: 230–244.
- Hu Y., Wang L., Yang G., Wang S., Guo M., Lu H., Zhan T. (2023). VDR promotes testosterone synthesis in mouse Leydig cells via regulation of cholesterol side chain cleavage cytochrome P450 (Cyp11a1) expression. Gen. Genom., 45: 1377–1387.
- Javed Z., Papageorgiou M., Deshmukh H., Kilpatrick E.S., Mann V., Corless L., Abouda G., Rigby A.S., Atkin S.L., Sathyapalan T. (2019). A randomized, controlled trial of vitamin D supplementation on cardiovascular risk factors, hormones, and liver markers in women with polycystic ovary syndrome. Nutrients, 11: 188.
- Jukic A.M.Z., Wilcox A.J., McConnaughey D.R., Weinberg C.R., Steiner A.Z. (2018). 25-Hydroxyvitamin D and long menstrual cycles in a prospective cohort study. Epidemiology, 29: 388–396.
- Kafali H., Iriadam M., Ozardali I., Demir N. (2004). Letrozole-induced polycystic ovaries in the rat: a new model for cystic ovarian disease. Arch. Med. Res., 35: 103–108.
- Kalamon N., Błaszczyk K., Szlaga A., Billert M., Skrzypski M., Pawlicki P., Górowska-Wójtowicz E., Kotula-Balak M., Błasiak A., Rak A. (2020). Levels of the neuropeptide phoenixin-14 and its receptor GRP173 in the hypothalamus, ovary and periovarian adipose tissue in rat model of polycystic ovary syndrome. Biochem. Biophys. Res. Commun., 528: 628–635.
- Kamińska K., Tchurzyk M., Fraczek O., Szlaga A., Sambak P., Tott S., Małek K., Knapczyk-Stwora K., Błasiak A., Rak A., Grzesiak M. (2024). Effect of vitamin D3 on uterine morphology and insulin signaling in a polycystic ovary syndrome (PCOS) rat model. Ann. Anim. Sci., 24: 1197–1209.
- Krishnan A.V., Swami S., Peng L., Wang J., Moreno J., Feldman D. (2010). Tissue-selective regulation of aromatase expression by calcitriol: implications for breast cancer therapy. Endocrinology, 151: 32–42.
- Kyei G., Sobhani A., Nekonam S., Shabani M., Ebrahimi F., Qasemi M., Salahi E., Fardin A. (2020). Assessing the effect of MitoQ10 and vitamin D3 on ovarian oxidative stress, steroidogenesis and histomorphology in DHEA induced PCOS mouse model. Heliyon, 6: e04279.
- Li J., Papadopoulos V., Vihma V. (2015). Steroid biosynthesis in adipose tissue. Steroids, 103: 89–104.
- Lundqvist J., Norlin M., Wikvall K. (2010). 1α, 25-Dihydroxyvitamin D3 affects hormone production and expression of steroidogenic enzymes in human adrenocortical NCI-H295R cells. Biochim. Biophys. Acta, 1801: 1056–1062.
- Mannerås L., Cajander S., Holmäng A., Seleskovic Z., Lystig T., Lönn M., Stener-Victorin E. (2007). A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome. Endocrinology, 148: 3781–3791.
- Marcondes F.K., Bianchi F.J., Tanno A.P. (2002). Determination of the estrous cycle phases of rats: some helpful considerations. Braz. J. Biol., 62: 609–614.
- Mason C., Xiao L., Imayama I., Duggan C., Wang C.Y., Korde L., McTiernan A. (2014). Vitamin D3 supplementation during weight loss: a double-blind randomized controlled trial. Am. J. Clin. Nutr., 99: 1015–1025.
- Mason C., Tapsoba J.D., Duggan C., Imayama I., Wang C.Y., Korde L., McTiernan A. (2016). Effects of vitamin D3 supplementation on lean mass, muscle strength, and bone mineral density during weight loss: a double-blind randomized controlled trial. J. Am. Geriatr. Soc., 64: 769–778.
- Masjedi F., Keshtgar S., Zal F., Talaei-Khozani T., Sameti S., Fallahi S., Kazeroni M. (2020). Effects of vitamin D on steroidogenesis, reactive oxygen species production, and enzymatic antioxidant defense in human granulosa cells of normal and polycystic ovaries. J. Steroid. Biochem. Mol. Biol., 197: 105521.
- Merhi Z., Doswell A., Krebs K., Cipolla M. (2014). Vitamin D alters genes involved in follicular development and steroidogenesis in human cumulus granulosa cells. J. Clin. Endocrinol. Metab., 99: E1137–E1145.
- Nteeba J., Ortinau L.C., Perfield J.W., Keating A.F. (2013). Diet-induced obesity alters immune cell infiltration and expression of inflammatory cytokine genes in mouse ovarian and peri-ovarian adipose depot tissues. Mol. Reprod. Dev., 80: 948–958.
- Patel S.S., Beshay V.E., Escobar J.C., Carr B.R. (2010). 17α-Hydroxylase (CYP17) expression and subsequent androstenedione production in the human ovary. Reprod. Sci., 17: 978–986.
- Pich K., Rajewska J., Kamińska K., Tchurzyk M., Szlaga A., Sambak P., Błasiak A., Grzesiak M., Rak A. (2023). Effect of vitamin D3 on chemerin and adiponectin levels in uterus of polycystic ovary syndrome rats. Cells, 12: 2026.
- Pich K., Pietroń K., Szlaga A., Billert M., Skrzypski M., Pawlicki P., Kotula-Balak M., Dupont J., Błasiak A., Rak A. (2025). Adipokines level in plasma, hypothalamus, ovaries and adipose tissue of rats with polycystic ovary syndrome. Reprod. Biomed. Online., 50: 104693.
- Prabhu Y.D., Borthakur A., Subeka A.G., Vellingiri B., Valsala Gopalakrishnan A. (2021). Increased pro-inflammatory cytokines in ovary and effect of γ-linolenic acid on adipose tissue inflammation in a polycystic ovary syndrome model. J. Reprod. Immunol., 146: 103345.
- Puttabyatappa M., Lu C., Martin J.D., Chazenbalk G., Dumesic D., Padmanabhan V. (2018). Developmental programming: impact of prenatal testosterone excess on steroidal machinery and cell differentiation markers in visceral adipocytes of female sheep. Reprod. Sci., 25: 1010–1023.
- Refaat B., El-Boshy M. (2021). Effects of supraphysiological vitamin D3 (cholecalciferol) supplement on normal adult rat ovarian functions. Histochem. Cell Biol., 155: 655–668.
- Ryan G.E., Malik S., Mellon P.L. (2018). Antiandrogen treatment ameliorates reproductive and metabolic phenotypes in the letrozole-induced mouse model of PCOS. Endocrinology, 159: 1734–1747.
- Ryu K.J., Park H., Han Y.I., Lee H.J., Nam S., Jeong H.G., Kim T. (2023). Effects of time-restricted feeding on letrozole-induced mouse model of polycystic ovary syndrome. Sci. Rep., 13: 1943.
- Salehpour A., Hosseinpanah F., Shidfar F., Vafa M., Razaghi M., Dehghani S., Hoshiarrad A., Gohari M. (2012). A 12-week double-blind randomized clinical trial of vitamin D3 supplementation on body fat mass in healthy overweight and obese women. Nutr. J., 11: 78.
- Schedel M., Jia Y., Michel S., Takeda K., Domenico J., Joetham A., Ning F., Strand M., Han J., Wang M., Lucas J.J., Vogelberg C., Kabesch M., O’Connor B.P., Gelfand E.W. (2016). 1,25D3 prevents CD8+Tc2 skewing and asthma development through VDR binding changes to the Cyp11a1 promoter. Nat. Commun., 7: 10213.
- Skarra D.V., Hernández-Carretero A., Rivera A.J., Anvar A.R., Thackray V.G. (2017). Hyperandrogenemia induced by letrozole treatment of pubertal female mice results in hyperinsulinemia prior to weight gain and insulin resistance. Endocrinology, 158: 2988–3003.
- Sun T., Zhao Y., Mangelsdorf D.J., Simpson E.R. (1998) Characterization of a region upstream of exon I.1 of the human CYP19 (aromatase) gene that mediates regulation by retinoids in human choriocarcinoma cells. Endocrinology, 139: 1684–1691.
- Sun W., Xie H., Ji J., Zhou X., Goltzman D., Miao D. (2010). Defective female reproductive function in 1,25(OH)2D-deficient mice results from indirect effect mediated by extracellular calcium and/or phosphorus. Am. J. Physiol. Endocrinol. Metab., 299: 928–935.
- Szyrzisko W., Grzesiak M. (2024). Periovarian adipose tissue – an impact on ovarian functions. Physiol. Res., 73: 1–8.
- van Tienhoven X.A., Ruiz de Chávez Gascón J., Cano-Herrera G., Sarkis Nehme J.A., Souroujon Torun A.A., Bautista Gonzalez M.F., Esparza Salazar F., Sierra Brozon A., Rivera Rosas E.G., Carbajal Ocampo D., Cabrera Carranco R. (2025). Vitamin D in reproductive health disorders: a narrative review focusing on infertility, endometriosis, and polycystic ovarian syndrome. Int. J. Mol .Sci., 26: 2256.
- Villaggio B., Soldano S., Cutolo M. (2012). Vitamin D modulates aromatase expression in human macrophages and downregulates proinflammatory cytokine production via ERK/MAPK signaling. Ann. Rheum. Dis., 71, Suppl 1: A75–A76.
- Vulcan T., Suciu T.S., Lenghel L.M., Toma V.A., Decea N., Moldovan R., Mitrea D.R., Baldea I., Filip G.A. (2024). The impact of vitamin D3 administration and of high fat diet on oxidative stress and inflammation in experimentally induced polycystic ovary syndrome. Med. Pharm. Rep., 97: 516–527.
- Wang H.H., Cui Q., Zhang T., Guo L., Dong M.Z., Hou Y., Wang Z.B., Shen W., Ma J.Y., Sun Q.Y. (2017). Removal of mouse ovary fat pad affects sex hormones, folliculogenesis and fertility. J. Endocrinol., 232: 155–164.
- Xu H., Qiu S., Lin P., Liao X., Lin Y., Sun Y., Zheng B. (2024). Vitamin D has therapeutic effects on obesity and hyperandrogenemia in PCOS mouse model induced by low dose DHEA and high-fat diet. BMC Womens Health, 24: 601.
- Xue Z., Zhuang J., Bai H., Wang L., Lu H., Wang S., Zeng W., Zhang T. (2022). VDR mediated HSD3B1 to regulate lipid metabolism and promoted testosterone synthesis in mouse Leydig cells. Gen. Genom., 44: 583–592.
- Yague J.G., Garcia-Segura L.M., Azcoitia I. (2009). Selective transcriptional regulation of aromatase gene by vitamin D, dexamethasone, and mifepristone in human glioma cells. Endocrine, 35: 252–261.
- Yang C.F., Liu W.W., Wang H.Q., Zhang J.L., Li K., Diao Z.Y., Yue Q.L., Yan G.J., Li C.J., Sun H.X. (2022). Gonadal white adipose tissue is important for gametogenesis in mice through maintenance of local metabolic and immune niches. J. Biol. Chem., 298: 101818.
- Yang L., Chen L., Lu X., Tan A., Chen Y., Li Y., Peng X., Yuan S., Cai D., Yu Y. (2018). Peri-ovarian adipose tissue contributes to intraovarian control during folliculogenesis in mice. Reproduction, 156: 133–144.
- Zhao S., Fernald R.D. (2005). Comprehensive algorithm for quantitative real-time polymerase chain reaction. J. Comput. Biol., 12: 1047e64.
DOI: https://doi.org/10.2478/aoas-2026-0005 | Journal eISSN: 2300-8733 (formerly 1642-3402) | Journal ISSN: 1642-3402
Language: English
Submitted on: Aug 19, 2025
Accepted on: Dec 3, 2025
Published on: Jun 4, 2026
Published by: National Research Institute of Animal Production
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2026 Wiktoria Szyrzisko, Kinga Kamińska, Patryk Sambak, Agata Szlaga, Jakub Wizner, Anna Błasiak, Agnieszka Rak, Małgorzata Grzesiak, published by National Research Institute of Animal Production
This work is licensed under the Creative Commons Attribution 4.0 License.